As mice deficient in a particular gene provide an increasing number of novel in vivo models, in vivo assays that examine immune function are becoming a central issue. We found that the sensitivities of in vivo and in vitro assays are strikingly different. These differences have important implication
In vitro screens and functional assays to assess receptor pharmacology
β Scribed by Matthew A. Sills
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 871 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
In the drug discovery process, compounds that demonstrate therapeutic potential must be free of undesirable side effects in order to reach the clinic. Compounds that interact with more than one target, such as a receptor, have the potential to elicit side effects, in comparison to those compounds that are selective for a single target. One predictive measure of whether a compound demonstrates specificity is to profile a compound's activity through a series of receptor binding assays in what is termed a safety screen. If a compound demonstrates activity, further studies are subsequently performed in functional assays in order to determine whether the compound possesses agonist or antagonist activity at that receptor. This article discusses some of the basic tenets of receptor pharmacology and their application to safety assessment.
π SIMILAR VOLUMES
## Abstract Screen printed electrodes (SPEs), in addition to their utility in the electrochemical quantification of compounds of pharmacological interest may be used (i) for studying the redox pattern of drug candidates by cyclic voltammetry, (ii) for electrochemical synthesis in microvolumes (micr